Hot issues
Supply chain complexity means that upper payment limits and Medicare maximum fair prices will fall disproportionately on pharmacies, leading to closures that threaten patient access to care.
Although the state won FDA approval for its importation program in January 2024, it has yet to implement the program.
Between November 2022 and June 2023, Amarvel Biotech sold over 200 kilograms of precursor chemicals to U.S. buyers with full knowledge that they would be used to make fentanyl.
Our analysis of data from June and July revealed hundreds of pharmaceutical shipments that entered the U.S. from facilities no one would expect, including unregistered Chinese exporters and alternative medicine clinics abroad.
The warning letter was one of about 100 is a new focus on deceptive direct-to-consumer drug advertisements.
The “green list” will help protect patients from unreliable, illegally compounded GLP-1s and simplify screening for border security.
PSM led a coalition of organizations urging leaders of the Senate HELP and House Energy and Commerce committees to help strengthen the FDA’s ability to protect Americans from unsafe and counterfeit medicines and medical products.
Our podcast covers the latest in pharma crime and medicine safety.
Like your information on video? Subscribe to our YouTube playlist!
90 countries. 769 arrests. 123 criminal networks. Over 50 million doses of fake medicine.
Learn what FDA found at this compounding facility.
Fake GLP-1 medications are putting lives at risk.
Click the images below to see more recent videos.